Attralus to Present New Data at 2021 American Society of Hematology Annual Meeting
November 04, 2021 09:00 ET
|
Attralus, Inc
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with...
Attralus Closes $116 Million Series B Financing
September 08, 2021 07:00 ET
|
Attralus, Inc
- Proceeds to advance pipeline of transformational pan-amyloid removal (PAR) therapeutics into the clinic - Financing led by Logos Capital and included other leading public healthcare funds - ...
Attralus Appoints Jake Bauer to Board of Directors
July 28, 2021 07:00 ET
|
Attralus, Inc
SOUTH SAN FRANCISCO, Calif., July 28, 2021 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with...